Rectal cancer

Al B. Benson, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Lucille A. Leong, Edward Lin, Michael G. Martin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. RyanLeonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Deborah A. Freedman-Cass, Kristina M. Gregory

Research output: Contribution to journalReview articlepeer-review

136 Scopus citations

Abstract

These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer.

Original languageEnglish
Pages (from-to)1528-1564
Number of pages37
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2012

Keywords

  • Combined Modality Therapy
  • Genetic Predisposition to Disease
  • Guidelines as Topic
  • Humans
  • Neoplasm Staging
  • Rectal Neoplasms/drug therapy
  • Risk Assessment
  • Vitamin D/metabolism

Fingerprint

Dive into the research topics of 'Rectal cancer'. Together they form a unique fingerprint.

Cite this